Skip to main content

Table 1 Clinical characteristics and endocrine parameters of CC responsive and non-responsive patients with polycystic ovary syndrome

From: Brachial-to-ankle pulse wave velocity as an independent prognostic factor for ovulatory response to clomiphene citrate in women with polycystic ovary syndrome

 

CC responders (n = 38)

CC non-responders (n = 24)

P value

Age (y)

30.5 ± 4.7

31.5 ± 3.7

0.38

BMI (kg/m 2 )

23.7 ± 5.6

25.7 ± 6.4

0.21

No. of patients with < 18.5 BMI (%)

4 (11)

3 (13)

0.83

No. of patients with 18.5 ≤ BMI < 25 (%)

22 (58)

9 (38)

0.19

No. of patients with 25 ≤ BMI < 30 (%)

6 (16)

7 (29)

0.22

No. of patients with ≥ 30 BMI (%)

6 (16)

5 (21)

0.74

Gravida*

0 (0–3)

1 (0–4)

0.26

Parity*

0 (0–1)

0 (0–1)

0.82

Waist (cm)

78.2 ± 12.4

84.0 ± 12.3

0.11

Hip (cm)

95.82 ± 9.1

96.9 ± 8.8

0.67

Waist-to-hip ratio

0.81 ± 0.06

0.88 ± 0.07

0.001

LH (mIU/ml)

10.7 ± 3.8

12.3 ± 7.3

0.25

FSH (mIU/ml)

7.0 ± 1.7

6.6 ± 1.1

0.32

LH/FSH

1.6 ± 0.6

1.8 ± 0.9

0.23

PRL (ng/ml)

12.1 ± 5.8

12.3 ± 7.3

0.92

E2 (pg/ml)

46.93 ± 20.6

50.2 ± 18.2

0.54

Testosterone (ng/ml)

78.5 ± 25.8

99.6 ± 33.9

0.11

Free testosterone (pg/ml)

0.80 ± 0.34

1.17 ± 0.69

0.006

DHEA-S (μg/dl)

2095 ± 683

2284 ± 814

0.50

  1. CC: clomiphene citrate, BMI: body mass index, DHEA-S: dehydroepiandrosterone sulfate.
  2. *Median (range).